Joyzyme Group Limited (HKG:8622)

Hong Kong · Delayed Price · Currency is HKD

0.1760

-0.0020 (-1.12%)

Oct 7, 2026, 3:15 PM HKT

Market Cap	90.72M -54.1%
Revenue (ttm)	37.53M +26.2%
Net Income	-5.85M
EPS	-0.01
Shares Out	515.47M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	272,000
Open	0.1860
Previous Close	0.1780
Day's Range	0.1760 - 0.1860
52-Week Range	0.1500 - 0.7500
Beta	0.81
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About Joyzyme Group

Joyzyme Group Limited, an investment holding company, engages in the research, production, and sale of male fertility in-vitro diagnostic (IVD) reagents in the People's Republic of China. The company provides biological reagents, including male fertility IVD reagents, parasite antibody detection reagents, and Epstein-Barr virus antibody detection reagent; healthcare products and supplements; and auxiliary reproductive supplies and equipment. The company sells its products directly to hospitals and medical institutions, as well as to distributor... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1992

Employees 98

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 8622

Full Company Profile

Financial Performance

In 2025, Joyzyme Group's revenue was 28.28 million, an increase of 11.53% compared to the previous year's 25.36 million. Losses were -5.01 million, 20.4% more than in 2024.

Financial numbers in CNY Financial Statements